Philips Secures FDA Clearance for SmartSpeed Precise, Advancing MRI Speed and Image Precision

Dual AI-Powered Imaging Software Set to Enhance Diagnostic Confidence and Workflow Efficiency in MRI

Philips’ SmartSpeed Precise represents a landmark innovation in MRI technology, receiving FDA 510(k) clearance as the industry’s first dual AI-powered image reconstruction software. The solution integrates Philips’ Compressed SENSE acceleration engine with two distinct AI algorithms—one for denoising and another for image sharpening—creating a highly efficient and intelligent imaging platform. This deep learning-based solution enables faster, clearer scans with a simplified, single-click workflow. By achieving FDA clearance, Philips validates the clinical safety and efficacy of SmartSpeed Precise, opening the door for widespread clinical adoption across its entire 1.5T and 3.0T MRI system portfolio, including existing installed systems.


Designed for real-world radiology demands, SmartSpeed Precise offers significant improvements in operational efficiency, scan speed, and image quality. The system delivers up to 3x faster scans and up to 80% sharper images, allowing radiology departments to handle greater patient volumes while maintaining diagnostic precision. With its one-click functionality and adaptable denoising settings, it supports both experienced and junior technologists, standardizing imaging results across patients and reducing variability. From challenging cases such as pediatric and elderly patients to high-demand areas like neurology and oncology, SmartSpeed Precise enhances workflow reliability, improves diagnostic confidence, and reduces patient discomfort through shorter exam times—including a sub-10-second brain scan.


As healthcare systems globally face increasing MRI demand amid staffing shortages and longer patient queues, Philips’ SmartSpeed Precise emerges as a scalable and cost-effective solution. Its compatibility with existing MRI hardware ensures hospitals and diagnostic centers can upgrade without major capital investment, extending high-performance imaging to more care settings. The FDA clearance underscores Philips’ commitment to clinical innovation, enabling providers to deliver more precise, accessible, and efficient diagnostic care. SmartSpeed Precise not only redefines the possibilities of AI in medical imaging but also sets a new benchmark in patient-centered radiology workflows.


MedTech Spectrum's Summary

FDA-Cleared Dual AI Breakthrough: Philips’ SmartSpeed Precise, now FDA 510(k)-cleared, is the industry’s first dual AI MRI reconstruction software, combining denoising and sharpening engines to deliver up to 3x faster scans and 80% sharper images—marking a pivotal advancement in AI-driven radiology.

Enhanced Workflow Efficiency and Imaging Precision: With a single-click, user-friendly interface, SmartSpeed Precise improves diagnostic consistency and throughput, enabling radiology departments to reduce patient backlogs, streamline operations, and confidently address complex cases across neurology, oncology, and cardiology.

Scalable, Cost-Effective Impact: Designed for both new and existing 1.5T and 3.0T Philips MRI systems, SmartSpeed Precise offers a transformative upgrade path without hardware changes—helping providers meet rising imaging demands while promoting accessibility, operational excellence, and patient comfort.